Cite
research paper The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.
MLA
Cooper, Nichola, et al. “Research Paper The Efficacy and Safety of B-Cell Depletion with Anti-CD20 Monoclonal Antibody in Adults with Chronic Immune Thrombocytopenic Purpura.” British Journal of Haematology, vol. 125, no. 2, Apr. 2004, pp. 232–39. EBSCOhost, https://doi.org/10.1111/j.1365-2141.2004.04889.x.
APA
Cooper, N., Stasi, R., Cunningham-Rundles, S., Feuerstein, M. A., Leonard, J. P., Amadori, S., & Bussel, J. B. (2004). research paper The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. British Journal of Haematology, 125(2), 232–239. https://doi.org/10.1111/j.1365-2141.2004.04889.x
Chicago
Cooper, Nichola, Roberto Stasi, Susanna Cunningham-Rundles, Michael A. Feuerstein, John P. Leonard, Sergio Amadori, and James B. Bussel. 2004. “Research Paper The Efficacy and Safety of B-Cell Depletion with Anti-CD20 Monoclonal Antibody in Adults with Chronic Immune Thrombocytopenic Purpura.” British Journal of Haematology 125 (2): 232–39. doi:10.1111/j.1365-2141.2004.04889.x.